13F HOLDINGS REPORT
NEA Management Company, LLC
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001012975-24-000496
Total Value
$1.84B
Positions
42
Other Managers
0
Confidential Omitted
No
Holdings (42)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARCELLX INC | ACLX | 3,745,262 | $312.8M | 17.04% |
| 2 | TEMPUS AI INC | TEM | 5,385,979 | $304.8M | 16.61% |
| 3 | VERONA PHARMA PLC | 925050106 | 5,584,753 | $160.7M | 8.75% |
| 4 | RHYTHM PHARMACEUTICALS INC | RYTM | 2,909,956 | $152.5M | 8.31% |
| 5 | SAVARA INC | SVRA | 24,471,264 | $103.8M | 5.65% |
| 6 | COURSERA INC | COUR | 12,867,769 | $102.2M | 5.57% |
| 7 | MBX BIOSCIENCES INC | MBX | 3,614,486 | $93.9M | 5.12% |
| 8 | CRISPR THERAPEUTICS AG | CRSP | 1,587,854 | $74.6M | 4.06% |
| 9 | NEXTNAV INC | NXNVW | 8,189,156 | $61.3M | 3.34% |
| 10 | ZENAS BIOPHARMA INC | ZBIO | 2,613,948 | $44.2M | 2.41% |
| 11 | MONTE ROSA THERAPEUTICS INC | GLUE | 7,692,298 | $40.8M | 2.22% |
| 12 | TREVI THERAPEUTICS INC | TRVI | 11,370,376 | $38.0M | 2.07% |
| 13 | KORRO BIO INC | KRRO | 1,090,793 | $36.5M | 1.99% |
| 14 | PHATHOM PHARMACEUTICALS INC | PHAT | 1,960,169 | $35.4M | 1.93% |
| 15 | AURINIA PHARMACEUTICALS INC | AUPH | 3,969,834 | $29.1M | 1.59% |
| 16 | CVRX INC | CVRX | 2,370,542 | $20.9M | 1.14% |
| 17 | BLACK DIAMOND THERAPEUTICS INC | BDTX | 4,448,757 | $19.4M | 1.05% |
| 18 | CELCUITY INC | CELC | 1,250,001 | $18.6M | 1.02% |
| 19 | GOSSAMER BIO INC | GOSS | 18,093,034 | $17.9M | 0.98% |
| 20 | ADAPTIMMUNE THERAPEUTICS PLC | ADTI | 17,079,778 | $16.2M | 0.88% |
| 21 | NKARTA INC | NKTX | 3,568,781 | $16.1M | 0.88% |
| 22 | ORIC PHARMACEUTICALS INC | ORIC | 1,500,000 | $15.4M | 0.84% |
| 23 | NEUEHEALTH INC | 10920V404 | 2,726,917 | $14.2M | 0.78% |
| 24 | INOZYME PHARMA INC | 45790W108 | 2,437,689 | $12.7M | 0.69% |
| 25 | GERON CORP | GERN | 2,776,409 | $12.6M | 0.69% |
| 26 | BUZZFEED INC | BZFDW | 3,833,473 | $10.2M | 0.56% |
| 27 | REGULUS THERAPEUTICS INC | 75915K309 | 6,467,802 | $10.2M | 0.55% |
| 28 | X4 PHARMACEUTICALS INC | XFOR | 14,986,793 | $10.0M | 0.55% |
| 29 | CHAMPIONS ONCOLOGY INC | CSBR | 1,713,720 | $8.3M | 0.45% |
| 30 | RENEO PHARMACEUTICALS INC | 75974E103 | 4,785,494 | $8.1M | 0.44% |
| 31 | DESKTOP METAL INC | 25058X303 | 1,439,892 | $6.7M | 0.37% |
| 32 | SAGIMET BIOSCIENCES INC | SGMT | 2,000,275 | $5.5M | 0.30% |
| 33 | SYNLOGIC INC | SYBX | 2,922,772 | $4.4M | 0.24% |
| 34 | ALLAKOS INC | 01671P100 | 6,147,260 | $4.0M | 0.22% |
| 35 | LEXICON PHARMACEUTICALS INC | LXRX | 2,382,286 | $3.7M | 0.20% |
| 36 | MARKER THERAPEUTICS INC | MRKR | 1,071,428 | $3.0M | 0.16% |
| 37 | INVENTIVA SA | IVEVF | 1,462,586 | $2.7M | 0.15% |
| 38 | AFFIMED NV | N01045207 | 442,648 | $1.5M | 0.08% |
| 39 | IKENA ONCOLOGY INC | 45175G108 | 600,063 | $1.0M | 0.06% |
| 40 | SENTI BIOSCIENCES INC | SNTI | 442,615 | $1.0M | 0.05% |
| 41 | WHEELS UP EXPERIENCE INC | WSUPW | 106,125 | $256,823 | 0.01% |
| 42 | MYND AI INC | MYND | 206,208 | $164,966 | 0.01% |